Log in | Register

Low Energy Reverse Osmosis System

For the latest pharmaceutical news and updates - Sign up now!
Loading...
Low Energy Reverse Osmosis System

The MegaRO™ Mk2 now produces up to 30m3/h of high purity water, removing up to 98% of dissolved inorganics and over 99% of large dissolved organics, colloids and particles, making it a leader solution for this type of water treatment. The MegaRO™ Mk2 features low pressure membranes, which significantly reduce operating pressure, and a variable speed drive meant to ensure that the pump always operates at its most energy efficient level, whatever the flow rate. The result is minimized energy consumption and lower operating costs. The MegaRO™ Mk 2 keeps the well proven MegaRO™ programmable user interface with modem and RS232 port for simple operation, monitoring and data logging. Other key features which have been retained include an integral 5µm pre-filter for membrane protection, permeate diversion on start-up to ensure water quality, and a timed recirculation rinse to reduce membrane fouling. Options include chemical dosing equipment for anti-scalant and sodium bisulphite, a concentrate rinse valve and automatic pH control.

Veolia Water Solutions & Technologies North America, Cary NC 27513. www.veoliawaterst.com or call 919 677 8310. 

 

 

 

 

 

 

 

Register or log in to send e-mail for more info

E-mail to a colleague

See company's other products

Join the Discussion
Rate Article:  Average 0 out of 5
register or log in to comment on this article!

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1

Blogs

The Tale of Two Deviations

The Tale of Two Deviations

Apr 23 | The QA Pharm

It stands to reason that pharmaceutical companies in compliance trouble also have problems with their Deviation Management and Corrective and Preventive Action (CAPA) System(s).

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Can the Combination of Creative Destruction and “Steve Jobs’ Traits” Lead to a “Pharma QbD Spring”?

Apr 16 | Girish Malhotra, PE, President, EPCOT International

The answer is an unequivocal yes but we need some outsiders who can conspire with the insiders who will be the flag bearers within the companies. Outsiders can be the counsels/co-conspirators to the insiders for the coup d'etat.

Multimedia

Lung Cancer Drug Treats Rare Lymphoma Tumors

Lung Cancer Drug Treats Rare Lymphoma Tumors

May 17 | Video

A new study found Xalkori effective in treating anaplastic lymphoma among children, an encouraging development for gene-targeted therapy.

Merck - 2012 Facility of the Year Award - Facility Integration

Merck - 2012 Facility of the Year Award - Facility Integration

May 14 | Video

Brian Morrissey, Senior Project Engineer, Merck Manufacturing Division, talks to Pharmaceutical Processing's Editor In Chief Mike Auerbach during INTERPHEX 2012 about the company's Vaccine Bulk Manufacturing Facility Program of Projects. The facility has won the Facility Integration award in the 2012 Facility of the Year Award competition sponsored by ISPE, INTERPHEX and Pharmaceutical Processing magazine.

Medicine from a Vending Machine?

Medicine from a Vending Machine?

May 3 | Video

A Chinese company is pushing for acceptance of traditional Chinese medicine with a machine that can dispense herbs.

Taking Precautions to Prevent Contagion

Taking Precautions to Prevent Contagion

Apr 29 | Video

With the recent outbreak of viruses such as SARS, bird flu and swine flu, officials and travelers are being extra careful about preventing the illnesses from being transmitted.

Top Stories and Headlines
EVERY DAY!

FREE Email Newsletter